Five-year survival after introduction of adjuvant treatment in stage III melanoma: A nationwide registry-based study
European Journal of Cancer · 2026
DOI: 10.1016/j.ejca.2025.116201 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Hildur Helgadottir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Pathology, Karolinska Institutet, Stockholm 171 77, Sweden; Theme Cancer, Karolinska University Hospital, Stockholm 171 76…. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Stockholm, Cancerfonden, Cancer Research Foundations of Radiumhemmet.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology and Pathology, Karolinska Institutet, Stockholm 171 77, Sweden; Theme Cancer, Karolinska University Hospital, Stockholm 171 76, Sweden. Electronic address: hildur.helgadottir@sll.se.
- Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg 418 77, Sweden; Department of Oncology, Sahlgrenska University Hospita…
- Rudbeck Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala 751 85, Sweden; Department of Oncology, Uppsala University Hospital, Entrance 101, First Level, Uppsala 751 85, Sweden. E…
- Department of Biomedical and Clinical Sciences, Linköping University, Linköping 581 83, Sweden; Regional Cancer Center South East Sweden, Regional Cancer Center Southeast Sweden and Department of Clinical and Experiment…
- Department of Clinical Sciences, Surgery, Lund University, Lund 22100, Sweden; Department of Surgery, Skåne University Hospital, Kristianstad 29133, Sweden. Electronic address: karolin.isaksson@med.lu.se.
- Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg 40530, Sweden; Department of Surgery, Sahlgrenska University Hospital, Västra Götalandsregionen, Gothenbur…
Förderung
- Region Stockholm
- Cancerfonden
- Cancer Research Foundations of Radiumhemmet
Zitieren
APA
Helgadottir, H., Ny, L., Ullenhag, G. J., Mikiver, R., Isaksson, K., & Olofsson Bagge, R. (2026). Five-year survival after introduction of adjuvant treatment in stage III melanoma: A nationwide registry-based study. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.116201
Vancouver
Helgadottir H, Ny L, Ullenhag GJ, Mikiver R, Isaksson K, Olofsson Bagge R. Five-year survival after introduction of adjuvant treatment in stage III melanoma: A nationwide registry-based study. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2025.116201
BibTeX
@article{Helgadottir2026,
author = {Helgadottir, Hildur and Ny, Lars and Ullenhag, Gustav J and Mikiver, Rasmus and Isaksson, Karolin and Olofsson Bagge, Roger},
title = {Five-year survival after introduction of adjuvant treatment in stage III melanoma: A nationwide registry-based study},
journal = {European Journal of Cancer},
year = {2026},
doi = {10.1016/j.ejca.2025.116201}
}
EUVIMED